US-based hair and skin cosmetic procedure provider LightRx Face & Body has entered a deal with Hologic to offer non-invasive body contouring treatment SculpSure.

Designed for non-invasive lipolysis of the abdomen, back, thighs and chin areas, SculpSure is said to help achieve a natural-looking and slimmer appearance.

The SculpSure device uses advanced light-based technology to destroy fat cells under the skin.

Prior to the decision, LightRx Face & Body president Rich Morgan conducted extensive research into the market. He said: “Our clientele has been searching for body contouring solutions that are safe, effective and affordable.

“It provides the clinically proven, state-of-the-art technology and results that our customers want.”

“After carefully reviewing the marketplace and conducting detailed comparison experiments, SculpSure became the clear choice for our company. It provides the clinically proven, state-of-the-art technology and results that our customers want.”

The new advanced Food and Drug Administration (FDA) approved laser treatment will be provided at each of LightRx Face & Body’s centres across the US.

LightRx regional director Teresa Schindlbeck said: “SculpSure is the cornerstone of our Treat2Complete plan because of the visible results and the device’s 90% client satisfaction rating.”

The company was founded in 2004 and also provides treatment for cellulite reduction, skin rejuvenation and laser hair removal.